• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience.

作者信息

Tessier Steven, He Rong, Greipp Patricia, Viswanatha David, Bessonen Kurt, Lasho Terra, Foran James, Arana-Yi Cecilia, Gangat Naseema, Tefferi Ayalew, Shah Mithun, Alkhateeb Hassan, Liu Shujun, Pardanani Animesh, Patnaik Mrinal, Al-Kali Aref

机构信息

Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN.

Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

出版信息

Blood Adv. 2024 Sep 24;8(18):4807-4811. doi: 10.1182/bloodadvances.2024013255.

DOI:10.1182/bloodadvances.2024013255
PMID:39042872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415849/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/11415849/71dc337b5dca/BLOODA_ADV-2024-013255-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/11415849/05ef9fc5c2a3/BLOODA_ADV-2024-013255-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/11415849/71dc337b5dca/BLOODA_ADV-2024-013255-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/11415849/05ef9fc5c2a3/BLOODA_ADV-2024-013255-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/11415849/71dc337b5dca/BLOODA_ADV-2024-013255-gr2.jpg

相似文献

1
Molecular and clinical characterization of ETNK1-mutated myeloid neoplasms: the Mayo Clinic experience.ETNK1 突变型髓系肿瘤的分子与临床特征：梅奥诊所的经验
Blood Adv. 2024 Sep 24;8(18):4807-4811. doi: 10.1182/bloodadvances.2024013255.
2
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.ETNK1 突变发生于多种髓系肿瘤，并非非典型慢性髓系白血病所特有。
Cancer. 2023 Mar 15;129(6):878-889. doi: 10.1002/cncr.34616. Epub 2022 Dec 29.
3
Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience.STAG2突变在髓系肿瘤中的临床及预后影响：梅奥诊所的经验
Blood Adv. 2023 Apr 25;7(8):1351-1355. doi: 10.1182/bloodadvances.2022007937.
4
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.野生型JAK2急性髓系白血病5年后发生JAK2 V617F突变的骨髓增殖性肿瘤：1例报告
Acta Haematol. 2013;129(1):23-5. doi: 10.1159/000342100. Epub 2012 Sep 19.
5
Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods.TP53 突变型髓系恶性肿瘤的特征分析及与免疫组织化学染色法检测的 P53 表达情况的比较
Int J Lab Hematol. 2020 Apr;42(2):e35-e37. doi: 10.1111/ijlh.13088. Epub 2019 Aug 7.
6
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.尽管分子格局相似，但CALR和JAK2突变的骨髓增殖性肿瘤之间存在临床病理差异：来自诊断实验室靶向新一代测序的数据。
Ann Hematol. 2017 May;96(5):725-732. doi: 10.1007/s00277-017-2937-6. Epub 2017 Feb 4.
7
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.NPM1突变可能会在形态学上被诊断为骨髓增生异常综合征或骨髓增生异常/骨髓增殖性肿瘤的病例中揭示急性髓系白血病。
Leuk Lymphoma. 2015;56(11):3222-6. doi: 10.3109/10428194.2015.1026900. Epub 2015 May 12.
8
Y220C mutations in patients with myeloid malignancies.髓系恶性肿瘤患者中的Y220C突变。
Leuk Lymphoma. 2024 Oct;65(10):1511-1515. doi: 10.1080/10428194.2024.2363440. Epub 2024 Jun 10.
9
TP53 mutation screening for patients at risk of myeloid malignancy.对有髓系恶性肿瘤风险的患者进行TP53基因突变筛查。
Leukemia. 2024 Jul;38(7):1604-1608. doi: 10.1038/s41375-024-02283-x. Epub 2024 May 25.
10
Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.伴有钙网蛋白突变的骨髓增殖性肿瘤具有独特的形态学特征。
Am J Clin Pathol. 2016 Mar;145(3):418-27. doi: 10.1093/ajcp/aqw005.

本文引用的文献

1
Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study.伴有中性粒细胞增多的 MDS/MPN 的特征、主要治疗方法和生存情况：一项基于人群的研究。
Blood Adv. 2023 Dec 26;7(24):7554-7563. doi: 10.1182/bloodadvances.2023011181.
2
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.非典型慢性髓系白血病和未另行指定的骨髓增生异常/骨髓增殖性肿瘤：2023年诊断、风险分层及管理更新
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
3
ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
ETNK1 突变发生于多种髓系肿瘤，并非非典型慢性髓系白血病所特有。
Cancer. 2023 Mar 15;129(6):878-889. doi: 10.1002/cncr.34616. Epub 2022 Dec 29.
4
ASXL1/2 mutations and myeloid malignancies.ASXL1/2 突变与髓系恶性肿瘤。
J Hematol Oncol. 2022 Sep 6;15(1):127. doi: 10.1186/s13045-022-01336-x.
5
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.成人 AML 的诊断与治疗：ELN 专家组代表发布的 2022 年国际专家建议
Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867.
6
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类：整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
7
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
8
Impact of somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage.体细胞突变对磷酸乙醇胺合成、活性氧生成及DNA损伤的影响。
Mol Cell Oncol. 2021 Feb 19;8(2):1877598. doi: 10.1080/23723556.2021.1877598. eCollection 2021.
9
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.ETNK1 突变诱导出一种诱变表型，这种表型可以用磷酸乙醇胺逆转。
Nat Commun. 2020 Nov 23;11(1):5938. doi: 10.1038/s41467-020-19721-w.
10
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.非典型慢性髓性白血病的综合基因组、功能和预后特征分析
Hemasphere. 2020 Nov 6;4(6):e497. doi: 10.1097/HS9.0000000000000497. eCollection 2020 Dec.